EPISODE · Sep 11, 2026 · 7 MIN
SHTG Digest — Friday September 11, 2026
from SHTG Daily Digest — Weiss Lab
No top-tier journal papers cleared the bar this cycle, but next-tier literature offered genetics-to-therapy signal on FCS (a novel APOA5 variant and an ApoC-II case series) alongside two olezarsen/zodasiran commentary pieces, while the industry side was quiet — everything found in the 5-day window on Arrowhead, Alnylam, or Ionis's lipid programs had already been covered in the prior cycle.
Embed this episode
Ready to play
SHTG Digest — Friday September 11, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.